Arkema

Specialty materials, bio-based chemistry and circular feedstock systems

Arkema's 2025 Universal Registration Document reports that 12% of revenue came from products based on renewable or recycled raw materials, and that 73% of sales were covered by a life-cycle assessment. The report also describes mass-balance work for bio-attributed raw materials and recycled packaging in parts of the portfolio. Public reporting does not establish one product-level record connecting feedstock origin, allocation, formulation, performance qualification and end-of-life outcome.

12% 2025 revenue based on renewable or recycled raw materials

73% 2025 sales covered by a life-cycle assessment

44.0 kg/t 2025 waste treated without recovery

70% Recycled packaging used at some industrial sites, up to

• Specialty monomers, polymers, additives, solvents, bio-based and recycled feedstocks
• Packaging, catalysts, process energy, water and supplier chain-of-custody records
• Post-industrial and post-consumer streams where a compatible recovery route exists

Outputs and residuals to resolve

• Adhesives, coatings, advanced polymers, high-performance materials and construction products
• Process waste, packaging, solvents and product streams entering customer applications
• Product-level allocation, performance qualification and recovery evidence remain open

First decision: Choose one Arkema polymer, adhesive or coating family. Map feedstock origin, allocation method, formulation, performance test, customer use and recovery route.

Arkema reports 12% of 2025 revenue from products based on renewable or recycled raw materials.

LCA signal

Arkema reports 73% of sales covered by a life-cycle assessment in 2025.

Feedstock signal

Arkema describes bio-attributed mass balance and recycled packaging work across its businesses.

Evidence boundary

Portfolio percentages do not establish one product-level material passport or customer qualification chain.

Decision boundary

The public record supports one bounded next move: Choose one Arkema polymer, adhesive or coating family. Map feedstock origin, allocation method, formulation, performance test, customer use and recovery route. It does not establish a buyer, commercial approval or supply agreement.

This is a public screening map. It separates company-disclosed flows from open qualification work. It does not convert a destination into a buyer or an announced ambition into operating capacity.

Turn portfolio share into product evidence

A revenue percentage is a useful signal. The decision requires one material with a clear spec and qualified application.

Next evidence: Select product, feedstock, allocation, test plan, customer and claim.

Make mass balance legible

Bio-attributed and recycled claims need a clear accounting boundary that a buyer can audit.

Next evidence: Join input mass, allocation rule, lot, certificate, product and statement.

Use LCA at the substitution gate

Life-cycle analysis can guide a material decision when the baseline, boundary and performance requirement are explicit.

Next evidence: Compare incumbent and alternative material across performance, footprint and recovery.

• 2025 Universal Registration Document Arkema, official report PDF https://www.arkema.com/files/live/sites/shared_arkema/files/downloads/investorrelations/en/finance/ARKEMA_URD_2025_UK_MEL.pdf
• CSR strategy Arkema, official sustainability hub https://www.arkema.com/global/en/investor-relations/corporate-governance/csr/
• Sustainability newsroom Arkema, official report and sustainability updates https://www.arkema.com/global/en/media/newsroom/sustainability/

Source hierarchy: filings and company disclosures first. The brief states what those sources support and leaves the unresolved plant, grade, permit, buyer and mass-balance questions explicit.

The next useful working session starts with: Choose one Arkema polymer, adhesive or coating family. Map feedstock origin, allocation method, formulation, performance test, customer use and recovery route.